Rating History for Durata Therapeutics (DRTX) by BofA/Merrill Lynch

Date Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/13/2012 New Coverage Buy
(N/A)
12.00
(N/A)
7.35 13.48 83.4% Details